Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.
Yale JF, Valiquett TR, Ghazzi MN, Owens-Grillo JK, Whitcomb RW, Foyt HL. Yale JF, et al. Among authors: valiquett tr. Ann Intern Med. 2001 May 1;134(9 Pt 1):737-45. doi: 10.7326/0003-4819-134-9_part_1-200105010-00010. Ann Intern Med. 2001. PMID: 11329231 Clinical Trial.
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
Maggs DG, Buchanan TA, Burant CF, Cline G, Gumbiner B, Hsueh WA, Inzucchi S, Kelley D, Nolan J, Olefsky JM, Polonsky KS, Silver D, Valiquett TR, Shulman GI. Maggs DG, et al. Among authors: valiquett tr. Ann Intern Med. 1998 Feb 1;128(3):176-85. doi: 10.7326/0003-4819-128-3-199802010-00002. Ann Intern Med. 1998. PMID: 9454525 Clinical Trial.